This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Viswanath Arutla: Innovator in Anticancer Research
Introduction
Viswanath Arutla is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. His innovative work focuses on creating compounds that can potentially combat various forms of cancer.
Latest Patents
Viswanath Arutla holds a patent for "Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof." This invention presents Chalcone linked Imidazolone compounds of formula A, which have shown efficacy against fifty-three human cancer cell lines. His research aims to provide new therapeutic options for cancer treatment.
Career Highlights
Arutla is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work is characterized by a commitment to advancing scientific knowledge and developing practical applications for his discoveries.
Collaborations
Some of his notable coworkers include Ramakrishna Gadupudi and Balakrishna Moku. Their collaborative efforts contribute to the success of their research projects and the advancement of cancer treatment methodologies.
Conclusion
Viswanath Arutla's innovative contributions to anticancer research highlight the importance of scientific inquiry in addressing critical health challenges. His work not only enhances our understanding of cancer treatment but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile